JP Patent

JP7700101B2 — 閉端ｄｎａおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法

Assigned to ジェネレーションバイオカンパニー · Expires 2025-06-30 · 1y expired

What this patent protects

Patent listed against Onpattro.

Drugs covered by this patent

Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals

Patent Metadata

Patent number: JP7700101B2
Jurisdiction: JP
Classification: —
Expires: 2025-06-30
Drug substance claim: No
Drug product claim: No
Assignee: ジェネレーションバイオカンパニー
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.